To mark the launch of Global Prison Trends 2018, the fourth edition in PRI’s annual flagship Global Prison Trends series, PRI will be hosting an Expert Panel and Reception on Tuesday 12 June at Linklaters LLP in London.
This event will offer insights into the most urgent and emerging issues facing criminal justice systems worldwide. Global Prison Trends 2018 will be presented by Olivia Rope, PRI’s Policy and Programme Manager, and copies will be available. The report covers key trends including on prison management and prison populations, filling a gap in analysis in this area.
4.30–5.45pm: Panel
Moderator: Alison Hannah, Executive Director, Penal Reform International
Introductory remarks: Representative of Linklaters LLP
Global Prison Trends 2018: Olivia Rope, Policy and Programme Manager, Penal Reform International (PRI)
The rise of drugs and violence in prisons: Marie Nougier, Head of Research and Communications, International Drug Policy Consortium (IDPC)
The rise of female prison populations: Holly Tuckwood, Legal Fellow, AdvocAid, Sierra Leone
The rise of life imprisonment: Professor Dirk van Zyl Smit, Professor of Comparative and International Penal Law at the University of Nottingham
5.45–7.00pm:
Join us for a drinks reception, thanks to the generosity of Linklaters LLP
A discussion on the ongoing challenges of Ireland's drug policy and its debate on the removal of criminal sanctions for the simple possession of drugs.
Whilst technically cannabis falls within the often strict regulations of the international drug control system, a range of countries have taken more progressive and liberal approaches to cannabis regulation with outliers to even legalising cannabis use and possession.
IOTOD aims to provide the most up-to-date information in the field of opioid addiction in Europe. If you work in the field of opioid addiction, this conference should not be missed.
Mexico, Austria, Switzerland and the Global Commission on Drug Policy organise a Vienna-Geneva dialogue on the direction and pending challenges facing the global drug control regime.